Ronald Chen, M.D., MPH, FASCO, FASTRO

Professional Background

Dr. Chen is an internationally-recognized expert in prostate cancer and bladder cancer. He has written several national guidelines for the American Urological Association (AUA) and the American Society of Clinical Oncology (ASCO) on the treatment of prostate cancer, and is frequently asked to speak across the US and internationally about the latest advances in taking care of prostate and bladder cancer patients. He has also written several textbooks and book chapters on prostate and bladder cancers -- which are read by urologists, radiation oncologists, medical oncologists and students internationally. Dr. Chen is a radiation oncologist with expertise in all forms of radiation treatment, including brachytherapy (seeds), external beam radiation (IMRT, IGRT), and stereotactic body radiation.

• MPH, Clinical Effectiveness, Harvard School of Public Health, Boston, MA
• MD, Medicine, Harvard Medical School, Boston, MA
• MD, Medicine, Harvard Medical School, Boston, MA
• Other, Radiation Oncology, Harvard Radiation Oncology Program, Boston, MA
• Residency, Radiation Oncology, Harvard Radiation Oncology Program, Boston, MA
• Internship, Internal Medicine, Massachusetts General Hospital, Boston, MA

• American Society for Radiation Oncology (ASTRO), Member, 2018 - Present
• American Society for Radiation Oncology (ASTRO), Association for Director of Radiation Oncology Programs best practices and standards for milestones/clinical competency working group, Member, 2018 - Present
• American Society of Clinical Oncology (ASCO), Genitourinary Cancer Guideline Advisory Group, Member, 2018 - 2022
• National Cancer Institute CCDR (Cancer Care Delivery Research) , Steering Committee, Member, 2018 - Present
• American Society of Clinical Oncology (ASCO), Quality Publications Task Force, Member, 2017 - Present
• American Society of Clinical Oncology (ASCO), Localized Prostate Cancer Treatment Guideline Endorsement Panel, Member, 2017 - Present
• American Society of Clinical Oncology (ASCO), CancerLinQ Discovery Research and Publications Committee, Member, 2017 - Present

Research

Overview

Dr. Chen's research focuses on improving treatments and cure rates for patients with the most aggressive cancers, and on reducing side effects and improving quality of life for patients after treatment. He leads several national and international clinical trials in prostate, bladder and testicular cancers. Dr. Chen has received many research grants from the National Cancer Institute, Department of Defense, and Patient-Centered Outcomes Research Institute for his research. He has published more than 170 peer-reviewed articles, many in the most prestigious medical journals.